CIMT 2025: Report on the 22 <sup>nd</sup> Annual Meeting of the Association for Cancer Immunotherapy
The 22<sup>nd</sup> Annual Meeting of the Association for Cancer Immunotherapy (CIMT) was held from May 12 to May 14, 2025, in Mainz, Germany. The event brought together 674 academic and clinical professionals from 27 countries across five continents. As a central forum for the global cancer immunotherapy community, the meeting facilitated in-depth discussions on the most recent advances in cancer immunology and immunotherapy. Dedicated sessions explored cutting-edge topics such as the interplay between the nervous and immune systems in cancer, as well as the application of artificial intelligence to decipher how antigen receptors recognize tumor antigens - insights that are shaping the development of next-generation immunotherapies. This report offers a summary of the most significant highlights and key takeaways from CIMT2025.
Authors
- Jan D. Beck (ORCID: https://orcid.org/0000-0002-0379-1915)
- Anindhita Meena Muralidharan
- Laura Klein
- Sophie-Christin Linkenbach
- Matthias Peter (ORCID: https://orcid.org/0000-0002-2160-6824)
- Ludvig Dahl
- Johanna Kiefer
- Nina Tagscherer
Institutions
- Johannes Gutenberg University Mainz (DE)
- University Medical Center of the Johannes Gutenberg University Mainz (DE)
- Cell and Gene Therapy Catapult (GB)
- BioNTech (Germany) (DE)
- BioNTech (United States) (US)
Publication Details
- Journal
- Human Vaccines & Immunotherapeutics
- Published
- 2025-10-04
- DOI
- https://doi.org/10.1080/21645515.2025.2563962
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00